Pages that link to "Q55999662"
Jump to navigation
Jump to search
The following pages link to Jean Bousquet (Q55999662):
Displaying 50 items.
- The public health implications of asthma (Q24649071) (← links)
- Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (Q26740215) (← links)
- National and regional asthma programmes in Europe (Q26795644) (← links)
- Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma (Q26829667) (← links)
- Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction (Q28168959) (← links)
- Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial (Q28192038) (← links)
- Efficacy of mequitazine in comparison with placebo assessed by ocular challenge with allergen in allergic conjunctivitis (Q28241209) (← links)
- Mometasone furoate: an effective anti-inflammatory with a well-defined safety and tolerability profile in the treatment of asthma (Q28242599) (← links)
- Rupatadine in allergic rhinitis and chronic urticaria (Q28272573) (← links)
- ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle (Q28355722) (← links)
- Temporal asthma patterns using repeated questionnaires over 13 years in a large French cohort of women (Q28533462) (← links)
- Associations between nitric oxide synthase genes and exhaled NO-related phenotypes according to asthma status (Q28730056) (← links)
- Eosinophilic Inflammation in Asthma (Q29031455) (← links)
- Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report (Q30234293) (← links)
- Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes (Q30238498) (← links)
- Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study (Q30239093) (← links)
- Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015. (Q30251797) (← links)
- Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11. (Q30251800) (← links)
- EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy (Q30394524) (← links)
- Systems medicine and integrated care to combat chronic noncommunicable diseases (Q30395763) (← links)
- Sublingual immunotherapy: World Allergy Organization position paper 2013 update (Q30440195) (← links)
- The implementation gap in asthma prevention and control? (Q31036236) (← links)
- ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma (Q33242321) (← links)
- Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care. (Q33439439) (← links)
- Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study (Q33617816) (← links)
- Immunotherapy in allergic rhinitis: a prevention for asthma? (Q33663785) (← links)
- Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop (Q33869631) (← links)
- Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey (Q33932043) (← links)
- Operational definitions of asthma in recent epidemiological studies are inconsistent (Q34062198) (← links)
- Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. (Q34090431) (← links)
- Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. (Q34202072) (← links)
- Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review (Q34239027) (← links)
- Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma (Q34312701) (← links)
- Specific immunotherapy in rhinitis and asthma. (Q34321324) (← links)
- The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation (Q34400987) (← links)
- Clinical relevance is associated with allergen-specific wheal size in skin prick testing. (Q34430387) (← links)
- Multiple in vitro and in vivo regulatory effects of budesonide in CD4 T lymphocyte subpopulations of allergic asthmatics (Q34515612) (← links)
- Allergic rhinitis and its consequences on quality of sleep: An unexplored area (Q34566964) (← links)
- Structure and classification of H1-antihistamines and overview of their activities. (Q34734498) (← links)
- Effect of 17q21 variants and smoking exposure in early-onset asthma (Q34857209) (← links)
- Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies (Q34984432) (← links)
- GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. (Q35004497) (← links)
- The fight against chronic respiratory diseases in the elderly: the European Innovation Partnership on Active and Healthy Aging and beyond (Q35028935) (← links)
- Comparison of two methods to report potentially avoidable hospitalizations in France in 2012: a cross-sectional study (Q35047602) (← links)
- Aging and asthma: pathophysiological mechanisms. (Q35090997) (← links)
- Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review (Q35121392) (← links)
- Microbial products in allergy prevention and therapy. (Q35131619) (← links)
- Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine (Q35166733) (← links)
- Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness (Q35523534) (← links)
- Inflammatory features of nasal mucosa in smokers with and without COPD. (Q35573166) (← links)